Starbucks shorts rebuild ahead of Tuesday earnings
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
SBUX gained 8% over the past week to close at $99.37, a move that outpaced the median of its closest restaurant peers yet coincided with the sharpest weekly rise in short interest the stock has seen in months.
Short positions climbed 15% over the past seven days to 43.1 million shares, roughly 3.8% of the free float. That weekly move is approximately 1.7 standard deviations above SBUX's own typical week, making it notable even if the absolute level is not extreme. The rebuild follows a period of covering: shorts had pulled back through early October, bottoming around 33.6 million shares on October 8, before reversing sharply. The lending market offers no amplifying tension here. Borrowing costs remain low at 0.51%, and availability is exceptionally loose at 2,257%, meaning there are roughly 22 shares still available to borrow for every one currently lent out. New shorts can enter at essentially no premium, which may partly explain why they are.
The Street is trimming rather than abandoning. Wells Fargo cut its target from $125 to $120 this week while holding its Overweight rating, and Citigroup moved in the same direction, lowering its neutral target from $112 to $104. JPMorgan made a similar move in late September, pulling its Overweight target to $105 from $112. The pattern across several banks is consistent: the direction of revisions is downward, but few are walking away from positive ratings. The mean analyst target stands near $111, about 11% above the current price, though that number is dragged by some more optimistic holdouts. EV/EBITDA has moved materially lower over the past 30 days, down roughly 2.3 turns to 18.7x, reflecting both a cheaper stock and some compression in near-term earnings estimates. On the positive side, EPS momentum ranks in the 96th percentile on a 30-day basis and the 94th on 90 days, suggesting that while targets are being cut, underlying earnings estimate revisions have been running ahead of the peer group.
The bull case rests on the revitalization plan under CEO Brian Niccol. North America same-store sales came in at 7.1% for the March quarter, guidance was raised, and management has pointed to $2 billion in cumulative cost savings with more than $800 million targeted by end of 2027. The bear case centres on structural margin risk. Coffee represents 10 to 15% of cost of goods sold, and management has guided only that $1-per-pound coffee inflation should ease in the second half of 2026. The U.S. contributes more than 90% of North American revenue and roughly 70% of consolidated global revenue, leaving the company heavily exposed to any softening in domestic consumer spending. China traffic remains a separate, slower-moving concern.
Retail attention is running well above its recent baseline. The Wikipedia views signal had a z-score of 2.96 as of late September, the highest attention reading in the dataset's recent window, though this series has not been measured to lead the company's reported financials and is better read as a gauge of public interest than of revenue momentum.
The most straightforward thing to watch is earnings on October 27. SBUX has posted positive next-day moves after each of its last two prints, gaining roughly 2.7% after the July quarter. Whether the short rebuild of the past week reflects positioning ahead of a print that disappoints on the China or margin line, or simply traders fading the 8% weekly rally, becomes clearer the moment the numbers drop.
Stocks in this article
See the live data behind this article on ORTEX.
Open SBUX on ORTEX →How this article was generated
- Generated
- 21 Oct 2026, 19:06
- Data as of
- 21 Oct 2026, 19:02
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.